PCAB Launches USP 800-based Distinction in Hazardous Drug Handling (HDH)

This Distinction Program recognizes pharmacies’ need to comply with USP 800 but also permits pharmacies to do so at their own pace. – Jon Pritchett, PCAB

Pharmacy Compounding Accreditation Board (PCAB), a service of Accreditation Commission for Health Care (ACHC), has released the compounding industry’s first Distinction in Hazardous Drug Handling (HDH). Based on USP 800, the recently released industry guidelines that describe practices and quality standards for handling hazardous drugs in healthcare settings aimed at promoting the safety of patients and workers as well as environmental protection standards, PCAB’s HDH standards reflect the efforts of a broad collective of industry experts.

PCAB recently collaborated with the International Academy of Compounding Pharmacists (IACP) and a task force consisting of compounding industry providers, consultants, surveyors, and policy makers to publish a Consensus Statement on the Handling of Drugs per USP Chapter 800.

“This Distinction Program recognizes pharmacies’ need to comply with USP 800 but also permits pharmacies to do so at their own pace,” said Jon Pritchett, PharmD, RPh, ACHC Associate Director of Pharmacy. Noting that some pharmacies are already compliant or close to complying with both the infrastructure and standards of practice aspects of USP 800, Pritchett continued, “This allows those pharmacies that are currently compliant to distinguish themselves while permitting others to assimilate these changes over a longer timeframe.” USP 800 was published on February 1, 2016; however, implementation was delayed until July 1, 2018, to permit entities additional time for implementation. Pharmacies seeking to achieve a Distinction in HDH must do so in combination with PCAB…

Full article from the Source…

Back to Top